Table 3.

Agreement between pathway and multidisciplinary team treatment decisions

	n*	WB-MRI staging pathway†		Standard staging pathway		Difference agreement, % (95% CI)
		Agreement	Disagreement	Agreement	Disagreement
All patients	183	180 (98%)	3 (2%)	181 (99%)	2 (1%)	−1% (−4 to 2)
Patients with metastatic disease	52	51 (98%)	1 (2%)	50 (96%)	2 (4%)	2% (−7 to 11)
Patients without metastatic disease	131	129 (98%)	2 (2%)	131 (100%)	0	−2% (−4 to 1)

Data are n (%) unless otherwise stated.

^*Four patients were missing at least one type of patient treatment decision.

^†WB-MRI plus additional generated tests.